A diagnosis of Tularemia, often called “rabbit fever,” can be alarming, particularly since it is a rare and serious bacterial infection typically acquired from animals or insect bites. Symptoms often begin suddenly with fever, fatigue, headache, and body aches. Depending on how the bacteria entered the body, patients may develop a skin ulcer and swelling in the lymph nodes near the infection site. While symptoms can be severe and debilitating, making daily routines extremely difficult, Tularemia is highly treatable when caught early.

Treatment is crucial to prevent the infection from spreading throughout the body, where it could affect the lungs (pneumonic tularemia) or become systemic. Prompt and effective antibiotic therapy drastically reduces the risk of complications and death. Since Tularemia can manifest in different forms ulceroglandular, glandular, pneumonic, or typhoidal, the choice of medication and duration of treatment depends on the severity of the illness and the way the infection presents in the patient (Centers for Disease Control and Prevention, 2022).

Overview of treatment options for Tularemia

The main goal of treating Tularemia is to eradicate the Francisella tularensis bacteria from the body. Because it is a bacterial infection, medications known as antibiotics are the single most important and effective treatment.

Antibiotic treatment targets the underlying cause directly, leading to resolution of symptoms and elimination of the infection. For severe or life-threatening forms of Tularemia, such as the pneumonic or typhoidal types, initial treatment typically requires hospitalization and intravenous (IV) antibiotics. For milder forms, treatment can sometimes be completed using oral antibiotics once the initial diagnosis is confirmed. Lifestyle changes or procedures are generally supportive and not primary treatments, though abscessed lymph nodes may occasionally require surgical drainage to aid recovery.

Medications used for Tularemia

Tularemia requires specific classes of antibiotics because the Francisella tularensis bacteria are capable of living inside the host’s cells, which many common antibiotics cannot penetrate effectively.

First-line Drug Class: Aminoglycosides Aminoglycosides are highly effective for all forms of Tularemia and are often considered the gold standard, particularly for severe infections. Streptomycin is traditionally the drug of choice, while gentamicin is a commonly used alternative. These medications are typically administered via injection or intravenously, especially for initial or serious infections. Patients treated with these drugs often see fever subside and overall condition improve within 24 to 48 hours of starting therapy.

Alternative Drug Class: Fluoroquinolones For patients with milder disease, or for those who cannot receive aminoglycosides, oral antibiotics from the fluoroquinolone class are frequently prescribed. Ciprofloxacin and levofloxacin are two examples. The benefit of these drugs is that they can often be taken at home, making them ideal for outpatient management once a severe infection is ruled out.

Other Alternatives: Doxycycline (a tetracycline) is another oral antibiotic option that can be used. Although symptoms may take longer to resolve with tetracyclines compared to aminoglycosides, they are a practical alternative for less severe cases (Infectious Diseases Society of America, 2023).

How these medications work

Antibiotics treat Tularemia by interfering with the Francisella bacteria’s vital processes, successfully penetrating host cells to kill the residing bacteria. Aminoglycosides like streptomycin bind to bacterial ribosomes, disrupting protein synthesis, which prevents growth and repair, leading to cell death.

Fluoroquinolones such as ciprofloxacin halt bacterial DNA repair and replication, preventing multiplication. These actions reduce fever, minimize organ damage, and accelerate the healing of skin ulcers.

Side effects and safety considerations

Because the first-line antibiotics for Tularemia are potent, they carry risks that require careful monitoring. Aminoglycosides (e.g., gentamicin) can cause kidney damage (nephrotoxicity) or inner ear issues like hearing loss (ototoxicity), requiring regular kidney function monitoring.

Fluoroquinolones (e.g., ciprofloxacin) carry warnings for tendon rupture and need caution in the elderly or those with heart rhythm problems. Tetracyclines (e.g., doxycycline) cause sun sensitivity.

Patients with pre-existing kidney disease may need adjusted doses. Seek immediate medical attention for severe side effects, such as allergic reactions, hearing loss, or reduced urination.

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. Centers for Disease Control and Prevention. https://www.cdc.gov
  2. Infectious Diseases Society of America. https://www.idsociety.org
  3. Mayo Clinic. https://www.mayoclinic.org
  4. MedlinePlus. https://medlineplus.gov

Medications for Tularemia

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Tularemia.

Found 1 Approved Drug for Tularemia

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin
Minocycline hydrochloride tablets, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae. Lymphogranuloma venereum caused by Chlamydia trachomatis. Psittacosis (Ornithosis) due to Chlamydophila psittaci. Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis. Nongonococcal urethritis, endocervical, or rectal infections in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis. Relapsing fever due to Borrelia recurrentis. Chancroid caused by Haemophilus ducreyi. Plague due to Yersinia pestis. Tularemia due to Francisella tularensis. Cholera caused by Vibrio cholerae. Campylobacter fetus infections caused by Campylobacter fetus. Brucellosis due to Brucella species (in conjunction with streptomycin). Bartonellosis due to Bartonella bacilliformis. Granuloma inguinale caused by Klebsiella granulomatis. Minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Escherichia coli. Klebsiella aerogenes Shigella species. Acinetobacter species. Respiratory tract infections caused by Haemophilus influenzae. Respiratory tract and urinary tract infections caused by Klebsiella species. Minocycline hydrochloride tablets, USP are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory tract infections caused by Streptococcus pneumoniae. Skin and skin structure infections caused by Staphylococcus aureus. (NOTE: Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.) When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections: Uncomplicated urethritis in men due to Neisseria gonorrhoeae and for the treatment of other gonococcal infections. Infections in women caused by Neisseria gonorrhoeae. Syphilis caused by Treponema pallidum subspecies pallidum. Yaws caused by Treponema pallidum subspecies pertenue. Listeriosis due to Listeria monocytogenes. Anthrax due to Bacillus anthraci s. Vincent’s infection caused by Fusobacterium fusiforme. Actinomycosis caused by Actinomyces israelii. Infections caused by Clostridium species. In acute intestinal amebiasis, minocycline may be a useful adjunct to amebicides. In severe acne, minocycline may be useful adjunctive therapy. Oral minocycline is indicated in the treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx. In order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. It is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high. Oral minocycline is not indicated for the treatment of meningococcal infection. Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by Mycobacterium marinum. To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride tablets, USP and other antibacterial drugs, minocycline hydrochloride tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances